Such agents include alpha-melanocyte-stimulating hormone (α-MSH) and cAMP-elevating agents, such as forskolin that were reported to increase the levels of MITF and melanoma antigens such as MART-1 and GP-100 [144, 145]. The gene discussed is STAMBP; the disease is melanoma.